MedTrace Logo

Pulsed Electric Field Ablation for Metastatic Breast Cancer

NCT07487844 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-03-23

No results posted yet for this study

Summary

This is a phase I trial of the safety of image-guided pulsed electric field (PEF) ablation for the locoregional treatment of superficial soft tissue lesions in adults with metastatic breast cancer using the AliyaTM Pulsed Electric Field System.

Conditions

Interventions

DEVICE

Pulsed Electric Field (PEF) System

Pulsed electric field (PEF) delivers short, high frequency electrical pulses that are intended to shrink or destroy tumors

BEHAVIORAL

Questionnaires

Participants will complete health related, quality of life questionnaires

PROCEDURE

Tumor Ablation

Undergo ablation via PEF

Sponsors & Collaborators

Principal Investigators

  • Ryan Kohlbrenner, MD · University of California, San Francisco

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-15
Primary Completion
2028-07-01
Completion
2028-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07487844 on ClinicalTrials.gov